-transparent.png){kind=logo}
The purpose of this phase II clinical trial was to evaluate the effectiveness of triazinate and pyrazofurin in the treatment of advanced breast cancer. Although an occasional patient experienced stability of disease, neither agent, as employed in this study, was able to produce an objective antitumor effect in this group of patients with previous chemotherapeutic exposure. At the dosages used in this study, neither agent can be recommended for further treatment of advanced breast cancer.
Related Publications
W C Nichols, and
L K Kvols, and
J N Ingle, and
J H Edmonson, and
D L Ahmann, and
J Rubin, and
M J O'Connell
January 1977,
Cancer treatment reports,
W C Nichols, and
L K Kvols, and
J N Ingle, and
J H Edmonson, and
D L Ahmann, and
J Rubin, and
M J O'Connell
January 2002,
Cancer investigation,
W C Nichols, and
L K Kvols, and
J N Ingle, and
J H Edmonson, and
D L Ahmann, and
J Rubin, and
M J O'Connell
January 1989,
Cancer chemotherapy and pharmacology,
W C Nichols, and
L K Kvols, and
J N Ingle, and
J H Edmonson, and
D L Ahmann, and
J Rubin, and
M J O'Connell
January 1976,
Cancer treatment reports,
W C Nichols, and
L K Kvols, and
J N Ingle, and
J H Edmonson, and
D L Ahmann, and
J Rubin, and
M J O'Connell
January 1977,
Cancer treatment reports,
W C Nichols, and
L K Kvols, and
J N Ingle, and
J H Edmonson, and
D L Ahmann, and
J Rubin, and
M J O'Connell
January 1979,
Cancer treatment reports,
W C Nichols, and
L K Kvols, and
J N Ingle, and
J H Edmonson, and
D L Ahmann, and
J Rubin, and
M J O'Connell
January 1981,
Cancer treatment reports,
W C Nichols, and
L K Kvols, and
J N Ingle, and
J H Edmonson, and
D L Ahmann, and
J Rubin, and
M J O'Connell
January 1979,
Cancer treatment reports,
W C Nichols, and
L K Kvols, and
J N Ingle, and
J H Edmonson, and
D L Ahmann, and
J Rubin, and
M J O'Connell
September 1976,
Cancer treatment reports,
W C Nichols, and
L K Kvols, and
J N Ingle, and
J H Edmonson, and
D L Ahmann, and
J Rubin, and
M J O'Connell
August 2009,
Oncology reports,
